SORL1 Polymorphisms in Mexican Patients with Alzheimer's Disease
Danira Toral-Rios1, Elizabeth Ruiz-Sánchez2, Nancy Lucero Martínez Rodríguez3
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
Genes
|April 23, 2022
Summary
Single Nucleotide Polymorphisms (SNPs) in the SORL1 gene are associated with Late-Onset Alzheimer's Disease (LOAD) risk in the Mexican population. Genetic interactions between SORL1 variants and APOE genotypes may increase LOAD risk.
Area of Science:
- Genetics
- Neuroscience
- Population Health
Background:
- Late-Onset Alzheimer's Disease (LOAD) is a complex neurodegenerative disorder with significant genetic components.
- The Apolipoprotein E (APOE) gene is a major genetic risk factor for LOAD.
- The Sortilin Related Receptor 1 (SORL1) gene has been implicated in Alzheimer's Disease (AD) pathogenesis.
Purpose of the Study:
- To evaluate the risk effect of 12 Single Nucleotide Polymorphisms (SNPs) in the SORL1 gene in the Mexican population.
- To investigate potential interactions between SORL1 SNPs and the APOE genotype in LOAD risk.
- To identify genetic markers for LOAD in the Mexican population.
Main Methods:
- Case-control study including 156 LOAD patients and 221 controls from the Mexican population.
- Genotyping of SORL1 polymorphisms using real-time PCR.
- APOE genotyping and analysis of allelic, genotypic, and haplotypic frequencies.
- Linkage Disequilibrium (LD) and interaction analyses between SNPs and APOE genotype.
Main Results:
- The A/A genotype in rs1784933 (SORL1) was associated with an increased risk of LOAD.
- Two blocks of high LD were identified within SORL1 variants.
- A significant interaction was observed between rs1784933 and other SORL1 variants (rs668387, rs689021, rs641120).
- A significant association was found between APOE ε4 allele carriers and the SORL1 variant rs2070045.
Conclusions:
- The rs1784933 polymorphism in SORL1 is associated with LOAD in Mexican patients.
- Interactions between APOE ε4 and SORL1 variants may contribute to increased LOAD risk in this population.
- SNPs in SORL1 may serve as potential genetic markers for LOAD, aiding clinical diagnosis and future research into sporadic AD in Mexico.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
696
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
696
Alzheimer's Disease: Treatment
272
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
272


